BOSTON, May 28, 2025 -- Aktis Oncology, Inc., an oncology company focused on unlocking the breakthrough potential of targeted radiopharmaceuticals for patient populations not addressed by existing platform technologies, today announced...
Panacos, Vitex Merging In $27M Stock Exchange, Plus Milestones (BioWorld Today)
News | 06. 04. 2004
Panacos Pharmaceuticals
Bringing together two infectious disease pipelines, Panacos Pharmaceuticals Inc. entered a definitive merger agreement with V.I. Technologies Inc., also called Vitex.
